Chairman, Radiation Oncology Rush Univ. Medical Center
Radiation Oncology
Dr. Ross Abrams, MD
|
|
Give Review
Dr. Ross Abrams practices Radiation Oncology. He researched medicine at Medical College of Wisconsin Affiliated Hospitals. He over the years received 5 awards: "America's Top Doctors", "Chicago Magazine: Top Doctors", "America's Top Doctors for Cancer", "Super Doctor" and "Top MD". Ross Abrams is a published doctor and has 55 publications published. The lastest was: 'ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy.' He accepts Medicare.
Publications
- ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy.
- RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncolog...
- Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer.
- Radiosensitizing effect of anti-HER2/neu agents: Report of 2 cases and review of the literature.
- Supportive care considerations during concurrent chemoradiotherapy for pancreatic adenoCarcinoma: lessons learned from clinical experience.
- Agreement Among RTOG Sarcoma Radiation Oncologists in Contouring Suspicious Peritumoral Edema for Preoperative Radiation Therapy of Soft Tissue Sarcoma of the Extremity.
- Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Thera...
- Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51.
- Split-course chemoradiotherapy for locally advanced non-small cell lung Cancer: a single-institution experience of 144 patients.
- A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenoCarcinoma. A Phase II trial of safety, ef...
- Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year Analysis of the U.S. Interg...
- Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic Cancer: results from the ACOSOG Z5031 trial.
- Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy an...
- The Influence of Total Nodes Examined, Number of Positive Nodes, and Lymph Node Ratio on Survival after Surgical Resection and Adjuvant Chemoradiation for Pancreatic C...
- Weight Gain in Advanced Non-Small-Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy is Associated With Superior Survival.
- Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.
- Variation in post-surgical lumpectomy cavity volume with delay in initiation of Breast irradiation because of chemotherapy.
- Differential methylation of cell-free circulating DNA among patients with pancreatic Cancer versus chronic pancreatitis.
- Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic Cancer.
- Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients.
- Evaluation of four volume-based image registration algorithms.
- Application of holographic display in radiotherapy treatment planning II: a multi-institutional study.
- Assessment of pancreatic Cancer care in the United States based on formally developed quality indicators.
- Combined modality treatment of resectable and borderline resectable pancreas Cancer: expert consensus statement.
- Elective clinical target volumes for conformal therapy in anoRectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
- Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic Cancer.
- Management of a patient with borderline resectable pancreatic Cancer. Case report and review.
- CholangioCarcinoma--what level of evidence should we have?
- Postresection CA 19-9 predicts overall survival in patients with pancreatic Cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
- Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospec...
- Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenoCarcinoma: a randomized controlled t...
- Comment on 'adjuvant therapy in pancreatic Cancer: a critical appraisal'.
- Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common Bile duct.
- A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy.
- Adjuvant concurrent chemoradiation for node-positive adenoCarcinoma of the duodenum.
- Adjuvant therapy for pancreatic Cancer: current status, future directions.
- Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell Lung carcinoma (NSCLC).
- Radiotherapy in the adjuvant management of pancreatic adenoCarcinoma.
- Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenoCarcinoma--part 3: update on 5-year surv...
- Radiochemotherapy in the management of pancreatic Cancer--part II: use in adjuvant and locally unresectable settings.
- Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung Cancer: a Ra...
- A feasibility study of Dynamic Phantom scanner for quality assurance of photon beam profiles at various gantry angles.
- A challenge to the therapeutic nihilism of ESPAC-1.
- High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central Nervous system involvement.
- Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell Lymphoma.
- Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenoCarcinoma: a review of studies and experience at The Johns Hopkins Hosp...
- Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma.
- Adult patients with supratentorial pilocytic Astrocytomas: a prospective multicenter clinical trial.
- Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
- Clinical research in pancreatic Cancer: the Radiation Therapy Oncology Group trials.
- Standard vs. radical pancreaticoduodenectomy for periampullary adenoCarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy su...
- Pancreatic Cancer.
- Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenoCarcinoma, part 2: randomized controlled...
- Communication.
Schools
Perelman School of Medicine University of Pennsylvania
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Sagamore Plus
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Chicago Magazine: Top Doctors
- America's Top Doctors for Cancer
- Super Doctor
- Top MD
Education
-
Medical College of Wisconsin Affiliated Hospitals -
University of Pennsylvania Health System -
Pennsylvania Hospital - University of Pennsylvania Health System -
Duke University Hospital -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Rush University Medical Center -
Rush Oak Park Hospital
Drug Facts
| NPI NUMBER | 1356317564 | |
| NPPES Provider LastName | ABRAMS | |
| NPPES Provider FirstName | ROSS | |
| NPPES Provider ZIPCode | 606123804 | |
| NPPES Provider State | IL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 67.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356317564 |
| Last Name Of The Provider | ABRAMS |
| First Name Of The Provider | ROSS |
| View All |
Similar Doctors
|
|
Dr. Katherine L. Griem, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fred Rosen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrzej J. Jakubowiak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosemary Carroll, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gershon Y. Locker, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Raminder Kumar, MD |
|
|
Dr. Sandeep K. Gurbuxani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Annie L. Oh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarika D. Jain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond C. Bergan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Yu Chen, MD |
|
|
Dr. Bobby Chawla, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Selina L. Chow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhishek A. Solanki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Andrea Karoff, LCSW |